Precision Medicine News and Updates | Precision Medicine Online
Precision Medicine Online provides the latest news for healthcare leaders and scientists interested in precision medicine and individualized approaches to treatment and prevention.
AstraZeneca to Share With Regulators Results From Truqap Trial in …
2 天之前 · NEW YORK – AstraZeneca on Monday said it will share with global regulatory authorities results from a Phase III trial that demonstrated improved radiographic progression …
Breaking News - Precision Medicine Online
2024年11月20日 · The approval is based on the objective response rate in a Phase IIb trial of previously treated, unresectable or metastatic biliary tract cancer patients.
Precision Oncology News - Precision Medicine Online
2024年11月18日 · The latest news on companion diagnostics and personalized cancer therapy from Precision Medicine Online.
Disease Research & Diagnostics News | Precision Medicine Online
News and analysis on disease research and diagnostics from Precision Medicine Online.
Breaking News - Precision Medicine Online
2024年11月11日 · Patients with MSI-high/dMMR advanced colorectal cancers had a 79 percent lower risk of disease progression or death on Opdivo-Yervoy compared to chemo.
Aptose Launches Phase I/II Study of FLT3 Inhibitor in Newly …
6 天之前 · NEW YORK – Aptose Biosciences on Wednesday said it began testing its multi-kinase inhibitor tuspetinib with azacitidine and AbbVie and Genentech's Venclexta (venetoclax) in a …
Genomics Research & Discovery | Precision Medicine Online
2024年10月8日 · The latest research news in genetics and genomics from Precision Medicine Online.
Is There a Role for Precision Medicine With GLP-1 Drugs?
2024年11月20日 · NEW YORK – Drugs targeting the glucagon-like peptide 1 (GLP-1) receptor have seized an outsized role in America's cardiometabolic health. By one estimate, more than …
Genomics Research & Discovery | Precision Medicine Online
2024年10月7日 · Qualifying participants in two projects will be referred to Genome Medical for genetic counseling and will be offered optional clinical germline genetic testing. Broad Institute …